(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of 5.64% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.91%.
Inogen's revenue in 2025 is $343,472,000.On average, 1 Wall Street analysts forecast INGN's revenue for 2025 to be $9,639,899,035, with the lowest INGN revenue forecast at $9,639,899,035, and the highest INGN revenue forecast at $9,639,899,035. On average, 1 Wall Street analysts forecast INGN's revenue for 2026 to be $10,743,146,947, with the lowest INGN revenue forecast at $10,743,146,947, and the highest INGN revenue forecast at $10,743,146,947.
In 2027, INGN is forecast to generate $10,713,402,518 in revenue, with the lowest revenue forecast at $10,713,402,518 and the highest revenue forecast at $10,713,402,518.